A study by Brickman et al. (2021), which used the Simoa method to measure plasma ATN biomarkers in a population clinically diagnosed with AD, found differences in the level of p-tau but not in t-tau, which is consistent with our findings. Here, MAPT is linked to Alzheimer disease.